RadRelease Pharmaceuticals

RadRelease Pharmaceuticals is a biotechnology startup focused on developing a novel drug delivery platform that utilizes ionizing radiation to trigger the controlled release of therapeutic agents. The company's core technology, licensed from Boise State University, involves specialized liposomes designed to encapsulate anticancer drugs and immunotherapy agents, releasing them precisely at the tumor site upon exposure to medical radiation. This approach aims to enhance the efficacy of cancer treatments while minimizing systemic toxicity by ensuring drugs are only active in the presence of targeted radiotherapy. RadRelease collaborates with academic institutions and industry partners like Perspective Therapeutics to advance its pipeline toward clinical applications in oncology.